Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

Volume: 128, Issue: 3, Pages: 985 - 996
Published: Feb 5, 2018
Abstract
BACKGROUND. Cytotoxic T lymphocyte–mediated (CTL-mediated) severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are rare but life-threatening adverse reactions commonly induced by drugs. Although high levels of CTL-associated cytokines, chemokines, or cytotoxic proteins, including TNF-α and granulysin, were observed in SJS-TEN patients in recent studies, the optimal treatment...
Paper Details
Title
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions
Published Date
Feb 5, 2018
Volume
128
Issue
3
Pages
985 - 996
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.